Covid-19: Saudi Arabia commits over Rs 3708 crore to vaccine development
Advertisement
Riyadh: The Saudi Arabian government has committed more than $500 million to funding efforts to develop and produce a safe and effective vaccine against the coronavirus disease, the country's health minister, Tawfig Al Rabiah, said ahead of the G20 Summit on Friday.
"The Kingdom has committed $500 million to support efforts to develop a vaccine against Covid-19," Al Rabiah remarked.
At the same event, Abdullah Al Rabiah, the supervisor general of the King Salman Humanitarian Aid and Relief Centre (KSrelief), said that Saudi Arabia will be one of the first countries to receive any vaccines against Covid-19.
Since the start of the pandemic, more than 354,800 cases of Covid-19 have been registered in Saudi Arabia, including the 286 new cases reported on Friday. The country has yet to experience a second wave similar to the rise in cases observed in Europe in fall.
Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.